N-terminal acetylation of transcription factor LIP induces immune therapy resistance via suppression of PD-L1 expression in non-small cell lung cancer
Background Programmed death-1 (PD-1) checkpoint blockade has revolutionized cancer therapy, yet its clinical success is confined to a subset of patients, underscoring the urgent need to understand the molecular underpinnings of programmed cell death ligand 1 (PD-L1) expression to combat immunotherap...
Saved in:
| Main Authors: | Xing Gao, Xiang He, Yongshuo Liu, Feiyu Tang, Yuxi Tian, Siyuan Gong, Jia Shen, Aimin Wang, Lunquan Sun, Wensheng Wei, Liang Weng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/11/e009905.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acetylation-enhanced Sp1 transcriptional activity suppresses Mlph expression
by: Chan Song Jo, et al.
Published: (2025-01-01) -
Illuminating the impact of N-terminal acetylation: from protein to physiology
by: Nina McTiernan, et al.
Published: (2025-01-01) -
Generation of Mature Nα-Terminal Acetylated Thymosin α1 by Cleavage of Recombinant Prothymosin α
by: Bo Liu, et al.
Published: (2013-01-01) -
Dual lysine and N‐terminal acetyltransferases reveal the complexity underpinning protein acetylation
by: Willy V Bienvenut, et al.
Published: (2020-07-01) -
Corrigendum to “CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription” [Transl Oncol. 2024 Sep;47:102038 /PMID: 38991463]
by: Ying Cui, et al.
Published: (2025-01-01)